Particle.news

Download on the App Store

CRISPR Study Ties DENND1A Regulatory Variants to Elevated Testosterone in PCOS

A two-step mapping with CRISPR activation demonstrates a causal route to testosterone overproduction in PCOS.

Overview

  • Peer-reviewed results in Nature Communications provide direct mechanistic evidence linking inherited regulatory DNA at DENND1A to hormone excess.
  • Activating DENND1A regulatory regions in human adrenal steroid–producing cells increased DENND1A expression and drove testosterone production in a PCOS model.
  • Researchers mapped more than 1,000 regulatory elements across 14 PCOS-associated loci, highlighting candidates such as FSHB and GATA4 for future interrogation.
  • The framework integrates high-throughput reporter assays with GWAS prioritization to pinpoint disease-relevant regulatory switches for functional testing.
  • Authors describe the work as proof-of-concept and plan to expand the approach to additional PCOS loci and more diverse populations to guide potential therapeutic targets.